Home > Insider Trading > Filing (0001209191-21-036711)

Filing Details

Accession Number:: 0001209191-21-036711
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-28 20:18:27
Reporting Period:: 2021-05-26

Accepted Time:: 2021-05-28 20:18:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651944	Dermtech Inc.	DMTK	Services-Medical Laboratories (8071)	842870849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1787129	Enrico Picozza	C/O Dermtech, Inc. 11099 N. Torrey Pines Rd. Suite 100 La Jolla CA 92037		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-26	4,497	$0.00	18,497	No	4	A	Direct
Common Stock	Acquisiton	2021-05-26	4,661	$0.00	23,158	No	4	A	Direct
Common Stock	Disposition	2021-05-26	20,297	$40.08	500,000	No	4	S	Indirect	By HLM Venture Partners IV, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	A	Direct
No	4	S	Indirect	By HLM Venture Partners IV, L.P.

Footnotes

The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stockunit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterlyinstallments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying anyvested restricted stock units shall be released to the reporting person on May 26, 2022.
The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stockunit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest, and the shares underlyingthe restricted stock units shall be released to the reporting person, on January 1, 2023, subject to the reporting person's continued service.
This transaction was executed in multiple trades at prices ranging from $40.00 to $40.32, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) of this Form 4.
The reporting person has a pecuniary interest in HLM Venture Associates IV, LLC ("HLM GP"). HLM GP is the general partner of HLM Venture Partners IV, L.P., which owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.